Clorox Company (The) (CLX) Announces Quarterly Earnings Results
Clorox Company (The) (NYSE:CLX) issued its quarterly earnings data on Wednesday. The company reported $1.46 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.41 by $0.05, Bloomberg Earnings reports. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.48 billion. During the same period last year, the business posted $1.36 earnings per share. Clorox Company (The)’s quarterly revenue was up 4.0% compared to the same quarter last year.
Shares of Clorox Company (NYSE:CLX) traded up 1.72% during midday trading on Wednesday, hitting $128.70. 1,068,234 shares of the company traded hands. The company has a 50-day moving average price of $130.69 and a 200-day moving average price of $133.82. The stock has a market capitalization of $16.61 billion, a P/E ratio of 24.12 and a beta of 0.39. Clorox Company has a 52 week low of $111.24 and a 52 week high of $141.76.
The company also recently declared a quarterly dividend, which will be paid on Monday, November 13th. Investors of record on Wednesday, October 25th will be given a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 2.66%. The ex-dividend date is Tuesday, October 24th. Clorox Company (The)’s dividend payout ratio (DPR) is currently 63.04%.
In related news, SVP Jon M. Balousek sold 9,223 shares of the stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the completion of the sale, the senior vice president now owns 20,614 shares of the company’s stock, valued at $2,862,666.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Dawn C. Willoughby sold 2,158 shares of the stock in a transaction that occurred on Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total transaction of $297,804.00. The disclosure for this sale can be found here. Insiders have sold 21,242 shares of company stock valued at $2,944,449 in the last three months. 1.00% of the stock is currently owned by corporate insiders.
Several analysts have commented on the stock. Jefferies Group LLC restated a “hold” rating and issued a $132.00 price objective on shares of Clorox Company (The) in a report on Wednesday. Royal Bank Of Canada reiterated a “hold” rating and set a $115.00 target price on shares of Clorox Company (The) in a report on Sunday, October 8th. BMO Capital Markets reiterated a “buy” rating and set a $150.00 target price on shares of Clorox Company (The) in a report on Thursday, October 5th. Zacks Investment Research lowered shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a report on Wednesday, October 4th. Finally, Barclays PLC reiterated an “equal weight” rating and set a $136.00 target price (down from $140.00) on shares of Clorox Company (The) in a report on Friday, August 4th. Three analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. The company has an average rating of “Hold” and an average price target of $127.39.
Clorox Company (The) Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.